Denali Therapeutics
DNLI
DNLI
203 hedge funds and large institutions have $2.88B invested in Denali Therapeutics in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 84 increasing their positions, 60 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 210 → 203 (-7)
15% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 34
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
203
Holding in Top 10
3
Calls
$4.24M
Puts
$1.93M
Top Buyers
| 1 | +$43.7M | |
| 2 | +$37.4M | |
| 3 | +$36.1M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$25M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$24.5M |
Top Sellers
| 1 | -$43.9M | |
| 2 | -$28M | |
| 3 | -$24.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$23.2M |
| 5 |
Holocene Advisors
New York
|
-$18.6M |